Related Experiment Video
Updated: May 31, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Effect of systemic antibiotics and topical chlorhexidine on meticillin-resistant Staphylococcus aureus carriage in
T Kypraios1, P D O'Neill, D E Jones
1School of Mathematical Sciences, University of Nottingham, Nottingham, UK.
Abstract:
Antibiotics and antiseptics have the potential to influence carriage and transmission of meticillin-resistant Staphylococcus aureus (MRSA), although effects are likely to be complex, particularly in a setting where multiple agents are used. Here admission and weekly MRSA screens and daily antibiotic and antiseptic prescribing data from 544 MRSA carriers on an intensive care unit (ICU) are used to determine the effect of these agents on short-term within-host MRSA carriage dynamics. Longitudinal data were analysed using Markov models allowing patients to move between two states: MRSA positive (detectable MRSA carriage) and MRSA negative (no detectable carriage). The effect of concurrent systemic antibiotic and topical chlorhexidine (CHX) on movement between these states was assessed. CHX targeted to MRSA screen carriage sites increased transition from culture positive to negative and there was also weaker evidence that it decreased subsequent transition from negative back to positive. In contrast, there was only weak and inconsistent evidence that any antibiotic influenced transition in either direction. For example, whereas univariate analysis found quinolones to be strongly associated with both increased risk of losing and then reacquiring MRSA carriage over time intervals of one day, no effect was seen with weekly models. Similar studies are required to determine the generalisability of these findings.
Insights
Topical chlorhexidine (CHX) effectively reduced meticillin-resistant Staphylococcus aureus (MRSA) carriage in ICU patients. Systemic antibiotics showed minimal impact on MRSA dynamics, suggesting CHX as a key intervention for MRSA control.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Pharmacy
Background:
- Meticillin-resistant Staphylococcus aureus (MRSA) poses a significant threat in intensive care units (ICUs).
- The influence of antibiotics and antiseptics on MRSA carriage is complex, especially with polypharmacy.
- Understanding within-host dynamics is crucial for effective MRSA transmission control.
Purpose of the Study:
- To investigate the impact of systemic antibiotics and topical chlorhexidine (CHX) on short-term MRSA carriage dynamics in ICU patients.
- To analyze the transition between MRSA-positive and MRSA-negative states based on antimicrobial and antiseptic use.
Main Methods:
- Analysis of longitudinal data from 544 MRSA carriers in an ICU setting.
- Utilized Markov models to assess patient transitions between MRSA carriage states.
- Correlated daily antibiotic and antiseptic prescribing data with MRSA screening results.
Main Results:
- Topical CHX significantly increased the transition from MRSA-positive to MRSA-negative states.
- Evidence suggested CHX also decreased the rate of MRSA reacquisition (negative to positive transition).
- Systemic antibiotics demonstrated weak and inconsistent effects on MRSA carriage transitions.
Conclusions:
- Topical CHX is a promising agent for reducing MRSA carriage in ICUs.
- Systemic antibiotics appear to have a limited role in modulating short-term MRSA carriage dynamics.
- Further research is needed to generalize these findings across different clinical settings.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Hand hygiene
Hand washing...
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...